The Lung Working Group, led by physician, Dr. Shruti Jolly (Michigan Medicine/MROQC Coordinating Center) and Dr. Peter Paximadis (Corewell Health South), and medical physicist, Dr. Martha Matuszak (Michigan Medicine/MROQC Coordinating Center), is currently working to identify ways to improve lung cancer treatment for patients across the state of Michigan.
Areas of Current & Ongoing Focus:
- Treatment technique and lung/esophagus toxicity evaluation (IMRT vs. 3DCRT)
- Impact of pretreatment cardiac disease and radiation doses on long term heart complications
- Understanding factors that contribute to poor patient outcomes post lung cancer treatment
- Uptake and toxicity implications of Immunotherapy in definitive lung cancer treatment
- Disparities in Lung Cancer Care
- Improving Quality of Radiation Treatment Plan and Delivery
- Lung Target Delineation
- Lung Target Coverage and Normal Tissue Dose Constraints
- Lung Motion Assessment
- Knowledge Based Planning (KBP) to improve radiation plan quality